Table 4.
Multivariable Analysis by Logistic Regression of Risk Factors for Treatment Failure in the Subgroup of Patients With a Non-MDRO Etiology
| Variable | Multivariate Analysis | Multivariable Propensity Score-Balanced Analysis | ||
|---|---|---|---|---|
| OR (95% CI) | P Value | OR (95% CI) | P Value | |
| Charlson comorbidity index | 1.293 (1.109–1.507) | .001 | 1.251 (1.071–1.461) | .005 |
| Number of vertebral levels | 1.968 (0.924–4.194) | .079 | 2.234 (1.020–4.893) | .045 |
| Oral treatment group | 0.487 (0.133–1.782) | .271 | 0.675 (0.173–2.632) | .571 |
| Propensity score | 0.042 (0.001–2.061) | .110 | ||
Abbreviations: CI, confidence interval; MDRO, multidrug-resistant organism; OR, odds ratio.